Rituximab: Progressive multi focal leukoencephalopathy (PML) can be associated with Rituximab treatment and with other drugs which cause immunosuppression. It is s rare complication. In one study 52 cases were reported in patients with lymphoma and other myeloproliferative diseases. The incidence was less than 1%. However the drug is being used more and more and the incidence may increase.
Answered 2/25/2017
3.6k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question